In-Person Access Only | 6.00 CE/CME Credits & MOC Points
Please read: All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $50 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team.
Total Health’s 2027 ASCO Direct™ Genitourinary Cancer Conference is an officially licensed ASCO Direct™ meeting. This Post-ASCO Genitourinary Cancers Symposium Review highlights key abstracts from top-rated presentations, providing attendees with direct access to the latest research and strategies in GU oncology education. The accredited meeting will be hosted as an in person meeting only available exclusively to registered participants.
Conference Agenda
Sunday, February 21, 2027
Program Chairs:
Brad McGregor, MD | Dana-Farber Cancer Institute
Kriti Mittal, MD | University of Massachusetts
7:30 AM
Coffee and Exhibits
8:00 AM
Program Chair Welcome
Brad McGregor, MD | Dana-Farber Cancer Institute
Kriti Mittal, MD | University of Massachusetts
8:10 AM
Evolving Perioperative Management of Bladder Cancer: Integrating Novel Therapies, ctDNA, and Emerging Evidence
Kriti Mittal, MD | University of Massachusetts
8:40 AM
Frontline Treatment of Advanced Urothelial Carcinoma: Current Standards and Emerging Strategies
David Aggen, MD, PhD | Memorial Sloan Kettering Cancer Center
9:10 AM
Treatment Sequencing in Metastatic Urothelial Carcinoma: Strategies Following Frontline Therapy
9:40 AM
Breakfast and Exhibits
9:55 AM
Non CME Breakfast
10:40 AM
Break and Refreshments
10:50 AM
Advancing Adjuvant and Frontline Therapy in Renal Cell Carcinoma: Emerging Evidence and Treatment Strategies
11:20 AM
Precision Approaches in Prostate Cancer: Perioperative Strategies, Biomarkers, and Emerging Evidence
11:50 AM
RTP Accredited Session: Decoding the Drivers of Decision-Making: Gaining Insight into Community Oncologists’ Implementation of Radioligand Therapy in the Management of Prostate Cancer
12:30 PM
Lunch and Exhibits
12:45 PM
Non CME Lunch
1:30 PM
Break and Refreshments
1:40 PM
Housekeeping and Survey
1:50 PM
Evolving Treatment Strategies in Advanced Prostate Cancer: Radiopharmaceuticals and Novel Systemic Approaches
Susan Slovin, MD, PhD | Memorial Sloan Kettering Cancer Center
2:20 PM
Beyond Clear Cell RCC: Emerging Evidence and Treatment Strategies in Non-Clear Cell Renal Cell Carcinoma
David McDermott, MD | Beth Israel Deaconess Medical Center
2:50 PM
Treatment of Refractory Renal Cell Carcinoma: Current Options and Emerging Therapeutic Strategies
Brad McGregor, MD | Dana-Farber Cancer Institute
3:20 PM
Break and Exhibits
3:35 PM
Expert Roundtable: Applying Emerging Evidence to the Management of Renal Cell Carcinoma
Moshe Ornstein, MD, MA | Cleveland Clinic
David Aggen, MD, PhD | Memorial Sloan Kettering Cancer Center
4:35 PM
Managing Treatment-Related Toxicities in GU Oncology: Practical Strategies for Clinical Practice
4:50 PM
ADJOURN
Agenda Subject To Change. All times are EST.
-
Apply the current standards of oncology care and key updates from national clinical guidance pathways to optimize the management of patients with various genitourinary cancers.
Review new, emerging, and novel therapeutic agents and treatment strategies and incorporate these into the management of patients with genitourinary cancers.
Communicate with members of the interprofessional oncology care team to improve collaborative performance in the management of patients with genitourinary cancers.
-
-
Free registration for all healthcare providers
Expert sessions that present the most clinically relevant data, research, and clinical strategies
Enduring video content for watching at your leisure
Real-time discussion and debate
Networking with peers, colleagues, and medical professionals
Access to the latest industry information and resources
Catered meals through-out the program